Skip to content
Clinical Trials – home

Prophylaxis against transplant rejection

  • 9 clinical trials
Quick filters

9 Clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Siplizumab
  • Sponsor:Itb-Med AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tx200-Tr101
  • Sponsor:Sangamo Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tacrolimus
  • Sponsor:Universitaetsklinikum Regensburg AöR
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Itb-Med AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tx200-Tr101
  • Sponsor:Sangamo Therapeutics France
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Tacrolimus
  • Sponsor:Astellas Pharma Europe Limited
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.